In a recent episode of Talking Sleep, Dr. Seema Khosla hosted Dr. Lee Neilson, an Assistant Professor of Neurology at the University of Iowa, to discuss his significant research on the connection between obstructive sleep apnea (OSA) and the risk of developing Parkinson's disease.
Read More
Dr. Neilson's study analyzed data from 13 million patients in the VA system to determine whether OSA could be a modifiable risk factor for neurodegenerative disorders, including Parkinson’s disease. The research sought to understand if treating sleep apnea might delay the onset of conditions like dementia.
Key methodological aspects of the study include how OSA was diagnosed through sleep testing and the criteria used for defining different severity levels. The study also detailed how Parkinson's disease was identified, using clinical notes and medication records. Dr. Neilson clarified that the analysis focused not only on Parkinson's but also considered other neurodegenerative diseases such as Alzheimer's.
The findings were thoroughly examined, particularly the impact of CPAP therapy on Parkinson’s risk after controlling for factors like BMI, diabetes, depression, and hypersomnia. The analysis aimed to understand the number needed to treat to prevent one case of Parkinson's disease and whether the hypoxic burden could be a mechanism in this context.
The conversation also ventured into related topics, such as distinguishing idiopathic REM sleep behavior disorder from trauma-related cases and the potential neuroprotective effects of smoking in the context of Parkinson’s disease.
A critical aspect of the discussion centered on whether the severity of OSA correlates with Parkinson's risk. Dr. Neilson addressed whether treating sleep apnea could prevent or merely delay dementia onset, as well as the ethics of withholding treatment from symptomatic patients in sleep apnea studies.
Dr. Neilson emphasized that the implications of this research could significantly influence how sleep medicine practitioners discuss the importance of treating OSA with patients and their families. Addressing sleep apnea could extend beyond alleviating immediate symptoms to potentially reducing long-term neurodegenerative risks, underscoring the necessity of adherence to treatment.
This episode offers valuable insights for healthcare providers focused on the relationship between sleep disorders and neurodegeneration.